IDEX Biometrics ASA
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of IDEX Biometrics ASA generated cash of -$27,090,315, which is more than the previous year. Cash used in financing activities reached the amount of $23,197,010 last year. Net change in cash is therefore -$4,208,826.

Cash Flow

IDEX Biometrics ASA (NASDAQ:IDBA): Cash Flow
2014 -14.14M -3.87M 42.42M
2015 -21.31M -72.69K 82.33M
2016 -26.80M -63.85K 135.57K
2017 -28.63M -587.58K 1.15M
2018 -24.60M -906.63K 446.03K
2019 -27.60M -719.76K 32.88M
2020 -23.29M -232K 17.43M
2021 -27.46M -143K 54.14M
2022 -31.89M -160K 14.50M
2023 -27.09M 4.01K 23.19M

IDBA Cash Flow Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Cash at beginning of period
15.59M33.75M7.29M14.12M9.49M34.67M64.86M88.34M25.93M6.25M
Operating activities
Net income
-26.71M-32.69M-32.46M-26.85M-32.19M-28.20M-30.60M-23.42M-25.75M-17.26M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
1.70M1.35M1.80M1.71M1.62M786.69K913.47K846.66K777.43K310.29K
Stock-based compensation expense
1.28M2.72M2.75M2.75M2.53M2.77M2.10M1.45M1.33M1.69M
Deferred income tax benefit 1.28M2.72M2.75M2.75M2.53M2.77M2.10M1.45M1.33M1.69M
Changes in operating assets and liabilities:
Accounts receivable, net
371.16K-548K-314K-414K68K00000
Inventories
-1.94M-3.21M-375K-139K469.07K00000
Accounts payable
-889.26K858K53K141K-1.09M00022.88M0
Cash generated by operating activities
-27.09M-31.89M-27.46M-23.29M-27.60M-24.60M-28.63M-26.80M-21.31M-14.14M
Investing activities
Purchases Of Investments
00000000-298.50K-633.90K
Investments In Property Plant And Equipment
-243.76K-267K-141K-333K-848.00K-1.03M-870.84K-157.32K-92.48K-3.91M
Acquisitions Net
0000000000
Cash generated by investing activities
4.01K-160K-143K-232K-719.76K-906.63K-587.58K-63.85K-72.69K-3.87M
Financing activities
Common Stock Issued
14.89M14.37M54.99M18.73M34.16M821.47K1.52M476.02K82.40M41.07M
Payments for dividends
0000000000
Repurchases of common stock
0000000000
Repayments of term debt
80.76M-400K-844K-793K000000
Cash used in financing activities
23.19M14.50M54.14M17.43M32.88M446.03K1.15M135.57K82.33M42.42M
Net Change In Cash
-4.20M-17.63M26.52M-6.82M4.57M-25.06M-28.07M-26.73M60.94M24.41M
Cash at end of period
11.38M16.12M33.82M7.29M14.06M9.60M36.79M61.61M86.88M30.66M
Data sourceData sourceData sourceData sourceData sourceData sourceData source